Kanova Bio is a Suzhou-based biopharmaceutical company focused on developing innovative antibody drugs for autoimmune diseases and oncology
Kanova Bio is a Suzhou-based biopharmaceutical company focused on developing innovative antibody drugs for autoimmune diseases and oncology. The company has several products in its pipeline, including XKH004, an IL-17A/F antibody, and XKH001, an IL-25 inhibitor, both of which are in various stages of clinical trials.